# Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis

> **NCT02124928** · — · UNKNOWN · sponsor: **Prim PD Dr Afshin Assadian** · enrollment: 400 (estimated)

## Conditions studied

- Atherosclerosis
- Carotid Artery Disease

## Interventions

- **PROCEDURE:** Carotid endarterectomy

## Key facts

- **NCT ID:** NCT02124928
- **Lead sponsor:** Prim PD Dr Afshin Assadian
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2015-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02124928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02124928, "Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02124928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*